Skip to main content
SpringerLink
Log in

Clevidipine

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Ericsson H, Fakt C, Höglund L, et al. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol 55: 61–67, Mar 1999

    Article  PubMed  CAS  Google Scholar 

  2. Schwieler JH, Ericsson H, Löfdahl P, Thulin T, Kahan T. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol 34: 268–274, Aug 1999

    Article  PubMed  CAS  Google Scholar 

  3. Nyberg G, Åhlund C, Elwien K, et al. Cardiovascular effects of an ultra-short-acting calcium antagonist, clevidipine, in healthy volunteers. Cardiovasc Drugs Ther 11 (Suppl 2): 379, Jun 1997

    Google Scholar 

  4. Kieler N, Jolin Å, Nordlander M, et al. Myocardial circulatory and metabolic effects of clevidipine when used to control postoperative hypertension after coronary artery bypass grafting. Anesth Analg 84 (Suppl): SCA50, No. 4S, Apr 1997

    Google Scholar 

  5. Kieler-Jensen N, Jolin-Mellgård Å, Nordlander M, et al. Myocardial circulatory and metabolic effects of clevidipine after coronary artery bypass grafting. Br J Anaesth 78 (Suppl 2): 6, Jun 1997

    Google Scholar 

  6. Ericsson H, Fakt C, Jolin-MellgÅrd Å, Norlander L, Sohtell M, et al. Clinical and pharmacokinetic results with a new ultrashort- acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Br J Clin Pharmacol 47: 531–538, May 1999

    Article  PubMed  CAS  Google Scholar 

  7. Kieler-Jensen N, Jolin-Mellgåd Å, Nordlander M, Ricksten SE. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Acta Anaesthesiol Scand 44: 186–193, Feb 2000

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clevidipine. Drugs R&D 3, 190–192 (2002). https://doi.org/10.2165/00126839-200203030-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203030-00010

Keywords

Search

Navigation